3tl5
From Proteopedia
(Difference between revisions)
m (Protected "3tl5" [edit=sysop:move=sysop]) |
|||
| Line 1: | Line 1: | ||
'''Unreleased structure''' | '''Unreleased structure''' | ||
| - | The entry 3tl5 is ON HOLD | + | The entry 3tl5 is ON HOLD until Paper Publication |
Authors: Murray, J.M., Wiesmann, C. | Authors: Murray, J.M., Wiesmann, C. | ||
Description: Discovery of GDC-0980: a Potent, Selective, and Orally Available Class I Phosphatidylinositol 3-Kinase (PI3K)/Mammalian Target of Rapamycin (mTOR) Kinase Inhibitor for the Treatment of Cancer | Description: Discovery of GDC-0980: a Potent, Selective, and Orally Available Class I Phosphatidylinositol 3-Kinase (PI3K)/Mammalian Target of Rapamycin (mTOR) Kinase Inhibitor for the Treatment of Cancer | ||
Revision as of 08:40, 30 October 2011
Unreleased structure
The entry 3tl5 is ON HOLD until Paper Publication
Authors: Murray, J.M., Wiesmann, C.
Description: Discovery of GDC-0980: a Potent, Selective, and Orally Available Class I Phosphatidylinositol 3-Kinase (PI3K)/Mammalian Target of Rapamycin (mTOR) Kinase Inhibitor for the Treatment of Cancer
